• By Susanne Posel – September 1, 2014

Last month, the International Cannabidiol Organization of Manufacturers and Research (ICOMR), a cannabidiol (CBD) industry watchdog group, released 2 independent laboratory tests of UltraCBD™ 200mg supplement which showed that the product contains less CBD than is marketed.

UltraCBD claims to provide 200 mg of CBD in their product; however according to ICOMR testing results provided by Iron Laboratories (IL):

• The conclusion of the ICOMR lab test results for the sample provided through Amazon showed that it contained “26.52 mg of cannabinoids in the entire sample – and 44.78% of the cannabindoid content was derived from THC.”
• The sample provided by UltraCBD was tested and results showedthat it contained 9.78 mg of cannabinoids in the 30-32 ml bottle.

In response to to the publication of the ICOMR laboratory results, UltraCBD provided a counter laboratory test from July 2014 that they paid AZ Med Testing (AZM) to conduct.

UltraCBD provided AZM with their product to be tested, preventing the ability to have an unbiased laboratory result.

According to the AZM laboratory results, UltraCBD contains 14.3% Cannabinoids or 4,290 mg/30ml bottle, which is 21 times the advertised retail concentration; however these results are expired and no longer valid as proof of the actual CBD content in their current products.

UltraCBD also accused ICOMR of a conspiracy by asserting that the ICOMR website “has probably existed for less than a few weeks with the purpose of attacking CBD competitors.”

Shockingly, the idea of selling CBD products that contain less CBD than is purported by the manufacturer may be an industry standard that only the consumer is unaware of.

In 2013, Alan Frankel, medical doctor in California and supporter of the use of CBD said that “for some people, taking one to two milligrams of CBD a day can have a positive effect.”

Frankel was commenting on independent laboratory test results conducted on Dixie X Dew Drops which “was found to contain a … small amount of CBD.”

In fact, the Werc Shop laboratory test results showed “CBD concentrations at significantly lower levels than the ‘approximately 100 mgs CBD and other cannabinoids’ promised on the label of the one once Dixie X Dew Drops … which retails for $40 per bottle.”

To explain away the fact that Dixie X Dew Drops contained only 45mg CBD, which is a significantly lower amount of CBD than claimed 100mg by the retailer, Frankel asserted: “A small dose like this might help with anxiety or seizures, but most patients need larger doses of CBD along with substantial amounts of THC.”

To further confuse the public as to the validity of their products, UltraCBD was a certified client of Doctors Trusted (DT), a “consumer protection organization” that “consists of seasoned entrepreneurs, qualified doctors and experienced marketers working together to make the internet a safer medium for consumers buying health and fitness products.”

DT accomplishes this goal by striving “to create a safer environment for online shopping, allowing customers to decide quickly whether a website meets acceptable safety standards. We give consumers the tools that they need to protect themselves and make informed purchasing decisions.”

Dr. Daniel Hanley, a member of DT, endorsed the UltraCBD website on behalf of DT, stating that the website was “trustworthy” and “safe” for consumers to purchase products from “at the time of this review”.

DT claims that Hanley “has no financial interest in ULTRA CBD and has no connection with ULTRA CBD whatsoever” and that Hanley only evaluated the UltraCBD website on the standpoint of their “medical claims and ethical business practices”.

By DT’s own admission, they “do not test the advertised products for potency”; yet clearly intimate that the products reviewed are safe by their marketing strategy of using the icon of a doctor in a white lab coat to give consumers the impression that a professional medical doctor had reviewed the certified website’s products.

After ICOMR provided DT with their laboratory results of UltraCBD, they suspended their certification of UltraCBD pending their own investigation.

While DT states that Hanley “has no financial interest in ULTRA CBD” it is clear by his profile on Elance that Hanley is a doctor who uses his medical expertise to provide recommendations for a price.

Hanley’s reviews can cost anywhere from $100 to $6,875 depending on the needs of the purchaser of the review. Dr. Hanley also “certifies” HempmedsPX, RSHO, Cibdex, Cibaderm and Canchew through DT.

DT’s large clientele of websites that are “certified” by their organization includes some of the largest suppliers of medical marijuana and CBD products in the industry.

HempMedsPX is the “corporate portfolio company of Medical Marijuana, Inc (MJNA)” and the main distributor to Kannaway, a “hemp-based network marketing company”.

Article source Occupy Corporatism